Volgen
Nick Scott
Nick Scott
Geverifieerd e-mailadres voor burnet.edu.au
Titel
Geciteerd door
Geciteerd door
Jaar
Covasim: an agent-based model of COVID-19 dynamics and interventions
CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, K Rosenfeld, GR Hart, ...
PLOS Computational Biology 17 (7), e1009149, 2021
5582021
Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality
D Headey, R Heidkamp, S Osendarp, M Ruel, N Scott, R Black, M Shekar, ...
The Lancet 396 (10250), 519-521, 2020
5002020
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ...
The Lancet 399 (10319), 61-116, 2022
3132022
The COVID-19 crisis will exacerbate maternal and child undernutrition and child mortality in low-and middle-income countries
S Osendarp, JK Akuoku, RE Black, D Headey, M Ruel, N Scott, M Shekar, ...
Nature food 2 (7), 476-484, 2021
1862021
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
N Scott, ES McBryde, A Thompson, JS Doyle, ME Hellard
Gut 66 (8), 1507-1515, 2017
1612017
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade
N Scott, JS Doyle, DP Wilson, A Wade, J Howell, A Pedrana, A Thompson, ...
International Journal of Drug Policy 47, 107-116, 2017
1432017
Gender inequalities in health and wellbeing across the first two decades of life: an analysis of 40 low-income and middle-income countries in the Asia-Pacific region
E Kennedy, G Binder, K Humphries-Waa, T Tidhar, K Cini, ...
The Lancet Global Health 8 (12), e1473-e1488, 2020
1122020
Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care
T Papaluca, L McDonald, A Craigie, A Gibson, P Desmond, D Wong, ...
Journal of Hepatology 70 (5), 839-846, 2019
1022019
Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: a randomized, controlled trial in people who inject drugs
AJ Wade, JS Doyle, E Gane, C Stedman, B Draper, D Iser, SK Roberts, ...
Clinical Infectious Diseases 70 (9), 1900-1906, 2020
942020
High‐frequency drug purity and price series as tools for explaining drug trends and harms in V ictoria, A ustralia
N Scott, JP Caulkins, A Ritter, C Quinn, P Dietze
Addiction 110 (1), 120-128, 2015
832015
Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30
D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ...
The Lancet Global Health 7 (9), e1180-e1188, 2019
792019
Gromov–Witten invariants of ℙ1 and Eynard–Orantin invariants
P Norbury, N Scott
Geometry & Topology 18 (4), 1865-1910, 2014
792014
Modelling the impact of relaxing COVID‐19 control measures during a period of low viral transmission
N Scott, A Palmer, D Delport, R Abeysuriya, RM Stuart, CC Kerr, D Mistry, ...
Medical Journal of Australia 214 (2), 79-83, 2021
78*2021
Cost‐effectiveness of treating chronic hepatitis C virus with direct‐acting antivirals in people who inject drugs in Australia
N Scott, DM Iser, AJ Thompson, JS Doyle, ME Hellard
Journal of gastroenterology and hepatology 31 (4), 872-882, 2016
682016
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
N Scott, E McBryde, P Vickerman, NK Martin, J Stone, H Drummer, ...
BMC medicine 13, 1-12, 2015
652015
Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study
A Palmer, N Scott, P Dietze, P Higgs
Harm reduction journal 17, 1-6, 2020
642020
Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020
N Scott, S Ólafsson, M Gottfreðsson, T Tyrfingsson, V Rúnarsdóttir, ...
Journal of hepatology 68 (5), 932-939, 2018
642018
A global investment framework for the elimination of hepatitis B
J Howell, A Pedrana, SE Schroeder, N Scott, L Aufegger, R Atun, ...
Journal of hepatology 74 (3), 535-549, 2021
612021
Australia needs to increase testing to achieve hepatitis C elimination
N Scott, R Sacks‐Davis, AJ Wade, M Stoove, A Pedrana, JS Doyle, ...
Medical Journal of Australia 212 (8), 365-370, 2020
592020
Innovative strategies for the elimination of viral hepatitis at a national level: a country case series
SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ...
Liver International 39 (10), 1818-1836, 2019
582019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20